在稳定性冠心病中合理使用心肌灌注显像的成本效益分析
Cost-effectiveness of the rational use of myocardial perfusion imaging in stable coronary artery disease
杨丽红 1曾艳 2李思进1
作者信息
- 1. 山西医科大学第一医院核医学科,太原 030001
- 2. 国投健康产业投资有限公司,北京 100032
- 折叠
摘要
我国心血管疾病死亡率较其他国家高,而在心血管疾病死亡原因中冠状动脉粥样硬化性心脏病(CAD)占首位.CAD治疗费用也高.费用的增加一方面与CAD发病率有关,另一方面也可能与不合理的诊疗方案有关.随着许多国家医疗保健成本的不断上升,诊断和治疗手段的成本效益问题变得越发重要.很多研究表明,大多数无创性检查比冠状动脉造影(CAG)具有更好的成本效益.该文主要综述心肌灌注显像(MPI)与CAG相比用于稳定性CAD的成本效益研究,并且比较了MPI与其他无创性检查的成本效益.
Abstract
China has the highest mortality rate from cardiovascular disease in the world and coro-nary artery disease(CAD)is the leading cause of death from cardiovascular disease.The cost of treatment for CAD is high,which is related to the incidence of CAD and possible irrational treatment protocols.How-ever,with the escalating costs of healthcare in most countries,the cost-effectiveness of diagnostic and man-agement testing is increasingly important.Many studies have shown that most non-invasive tests are more cost-effective than coronary angiography(CAG).This article reviews the cost-effectiveness of MPI compared with CAG and other non-invasive tests.
关键词
冠心病/心肌灌注显像/费用效益分析/发展趋势Key words
Coronary disease/Myocardial perfusion imaging/Cost-benefit analysis/Trends引用本文复制引用
出版年
2024
NETL
NSTL
万方数据